Position in DNLI
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$12,532,789
+$11,778,653 QoQ
Shares Held
487,278
+1140.6% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#47
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Derivatives in DNLI
reported options exposure · as of Mar 31, 2026CallValue
$576,000
CallShares
30,000
PutValue
$576,000
PutShares
30,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. DNLI ranks #31 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in DNLI
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,532,789 | 487,278 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $576,000 | 30,000 | Call | Defined | 2026-05-11 | |
| 2026-03-31 | $576,000 | 30,000 | Put | Defined | 2026-05-11 | |
| 2026-03-31 | $754,136 | 39,278 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $510,901 | 30,945 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $216,869 | 14,936 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $1,067,645 | 76,315 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,637,482 | 194,004 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,397,467 | 166,706 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,759,017 | 94,714 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,034,473 | 44,551 | Shares | Defined | 2024-08-12 | |
| 2024-06-30 | $1,390,878 | 59,900 | Call | Defined | 2024-08-12 | |
| 2024-03-31 | $7,847,176 | 382,416 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $3,031,782 | 141,276 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,853,314 | 138,309 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $3,187,876 | 108,027 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $4,800,152 | 208,340 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,563,017 | 128,120 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $5,912,182 | 192,642 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,290,685 | 111,814 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,138,301 | 35,384 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,368,992 | 120,381 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $5,500,311 | 109,025 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $5,117,974 | 65,247 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $3,984,095 | 69,774 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,473,757 | 17,595 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $248,803 | 6,944 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,205,710 | 49,864 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $662,998 | 37,864 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||